1. New handbook urges scholars to defend evidence, not just ideas Public health science under pressure: New handbook maps risks for researchers Democratic backsliding now affects many countries, prompting an...
=1. Mpox joins the mRNA club: BioNTech’s first in-human BNT166a data hint at broad orthopox potential—but neutralizing titers fade fast In this phase 1, first-in-human, open-label dose escalation study, healthy Vaccinia...
Extreme case report: more than 200 vaccine doses in 29 months A 62-year-old man from Magdeburg, Germany, received 217 COVID-19 vaccine doses over 29 months, with at least 134 doses documented in official records[1,3]...
For decades, the United States was the archetypal “vaccine nation” – a country that combined scientific innovation, regulatory strength, and broad uptake to drive vaccine‑preventable diseases to historic lows. Measles...
Asia (including Southeast Asia, China, and India) India – CDSCO/SEC pauses Bharat Biotech MTBVAC Phase III authorisation (6 June 2026) India’s Subject Expert Committee identified data gaps and a serious adverse...
1. RSV-B fights back: French surveillance flags notable nirsevimab escape, stressing need for smarter long-term RSV strategies This multicenter prospective cohort (POLYRES) from 32 French hospitals (Sept 2024–Apr 2025)...
One of the questions that has driven Global Health Press for years is surprisingly simple: Why do vaccination systems produce different outcomes, even when countries often share similar goals? To help answer that...
The rapidly escalating Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda is more than a regional health emergency. It is another stress test of whether the world has genuinely learned anything...
When vaccination is discussed, the focus is usually on vaccines, coverage rates, disease outbreaks, or vaccine hesitancy. Yet one of the most important drivers of vaccination success often remains invisible: the...
1. Ocular Lyme Diseases This retrospective case series synthesizes 27 published reports of ocular Lyme disease between 1988 and 2025, detailing 38 patients with diverse eye manifestations. Uveitis accounted for 45% of...